Welcome to LookChem.com Sign In|Join Free
  • or
2-METHYL-1,3-THIAZOLE-4-CARBOTHIOAMIDE, commonly known as methimazole, is a pharmaceutical compound primarily used in the treatment of hyperthyroidism or overactive thyroid conditions. It functions by inhibiting the synthesis of thyroid hormones, thus helping to regulate the body's metabolic processes. Methimazole is typically administered orally in tablet form and is also utilized to prepare patients for thyroid surgery or radioactive iodine treatment. It is crucial to adhere to the prescribed dosage and administration guidelines provided by healthcare professionals to ensure safe and effective treatment.

174223-29-1

Post Buying Request

174223-29-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

174223-29-1 Usage

Uses

Used in Pharmaceutical Industry:
2-METHYL-1,3-THIAZOLE-4-CARBOTHIOAMIDE is used as an antithyroid medication for the treatment of hyperthyroidism, a condition characterized by excessive thyroid hormone production. It is effective in reducing the levels of thyroid hormones, such as thyroxine (T4) and triiodothyronine (T3), thereby alleviating the symptoms and complications associated with hyperthyroidism.
2-METHYL-1,3-THIAZOLE-4-CARBOTHIOAMIDE is used as a pre-treatment agent for patients undergoing thyroid surgery or radioactive iodine treatment. By reducing the levels of thyroid hormones, it helps to minimize the risks and complications associated with these procedures.
In addition to its primary use in treating hyperthyroidism, 2-METHYL-1,3-THIAZOLE-4-CARBOTHIOAMIDE may also have potential applications in other areas of medicine, such as research into thyroid hormone regulation and the development of new therapeutic agents for related conditions. However, it is essential to consider the potential side effects, such as nausea, vomiting, and allergic reactions, as well as the possibility of interactions with other medications, when using 2-METHYL-1,3-THIAZOLE-4-CARBOTHIOAMIDE for any purpose.

Check Digit Verification of cas no

The CAS Registry Mumber 174223-29-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,2,2 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 174223-29:
(8*1)+(7*7)+(6*4)+(5*2)+(4*2)+(3*3)+(2*2)+(1*9)=121
121 % 10 = 1
So 174223-29-1 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N2S2/c1-3-7-4(2-9-3)5(6)8/h2H,1H3,(H2,6,8)

174223-29-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Methylthiazole-4-carbothioamide

1.2 Other means of identification

Product number -
Other names 2-METHYL-1,3-THIAZOLE-4-CARBOTHIOAMIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:174223-29-1 SDS

174223-29-1Relevant academic research and scientific papers

Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors

Chen, Fei,Chai, Hui,Su, Ming-Bo,Zhang, Yang-Ming,Li, Jia,Xie, Xin,Nan, Fa-Jun

supporting information, p. 628 - 633 (2014/07/07)

Inspired by the thiazole-thiazoline cap group in natural product largazole, a series of structurally simplified bisthiazole-based histone deacetylase inhibitors were prepared and evaluated. Compound 8f was evaluated in vivo in an experimental autoimmune encephalomyelitis (EAE) model and found to be orally efficacious in ameliorating clinical symptoms of EAE mice.

Total synthesis and complete structural assignment of thiocillin i

Aulakh, Virender S.,Ciufolini, Marco A.

supporting information; experimental part, p. 5900 - 5904 (2011/06/10)

The total synthesis of the thiopeptide antibiotic, thiocillin I, is described. This work unequivocally defines the full structure (constitution and configuration) of the natural product as 1.

An improved synthesis of pyridine-thiazole cores of thiopeptide antibiotics

Aulakh, Virender S.,Ciufolini, Marco A.

supporting information; experimental part, p. 5750 - 5753 (2009/12/06)

(Figure Presented) The oxidation of 2-methylthiazoles to 2-formylthiazoles simplifies the implementation of the Bagley variant of the Bohlmann-Rahtz reaction as a key step in a concise new route to pyridine cores of thiopeptide antibiotics.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 174223-29-1